increase, decrease, tumor inflammatory genes Gremlin (GREM1), interleukin 1 (IL-1), interleukin-4 [IL-4], nuclear factor B subunit 1 (NFB1), and prostaglandin-endoperoxide synthase 2 (PTGS2), extracellular signal-regulated kinase (ERK), c-jun N-terminal kinase (JNK), light chain 3 protein B II (LC3BII), c-Jun N-terminal kinase (JNK), poly(ADP ribose) polymerase (PARP)-1, nuclear factor-kappa B (NF-kappaB), cyclooxygenase-2 (Cox-2), extracellular signal-regulated protein kinase (ERK1/2), mitogen-activated protein kinase (MAPK), 7,12-dimethylbenz(a)anthracene (DMBA)-initiated and 12-O-tetradecanoylphorbol-13-acetate (TPA), metalloproteinases MMP
While the review has so far found no conclusive evidence of association, reports circulating without the proper contextual information may fuel disinformation and discourage patients who would benefit from GLP-1 RA therapy
Is MS a primary cytodegeneration
However, the review stresses that direct attribution of these effects to GLP-1R-mediated anti-inflammatory pathways remains to be conclusively demonstrated